These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2272363)

  • 1. Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats.
    Kamei J; Tanihara H; Kasuya Y
    Eur J Pharmacol; 1990 Oct; 187(2):281-6. PubMed ID: 2272363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The abilities of specific kappa-opioid agonists, U-50,488H and U-62,066E, to cause antitussive tolerance were lower than that of morphine.
    Kamei J; Tanihara H; Kasuya Y
    Jpn J Pharmacol; 1991 Aug; 56(4):557-61. PubMed ID: 1744997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of kappa-mediated antitussive activity in rats by a delta-agonist.
    Kamei J; Tanihara H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1992 Jun; 76(3):375-8. PubMed ID: 1321982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of mu-opioid receptors in the antitussive effects of pentazocine.
    Kamei J; Katsuma K; Kasuya Y
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):203-8. PubMed ID: 1314961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of opioidergic and serotonergic mechanisms in cough and antitussives.
    Kamei J
    Pulm Pharmacol; 1996; 9(5-6):349-56. PubMed ID: 9232674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat.
    Ohno M; Yamamoto T; Ueki S
    Psychopharmacology (Berl); 1992; 106(1):31-8. PubMed ID: 1346721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitussive effects of mu- and kappa-agonists in diabetic rats.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Neurosci Lett; 1993 May; 154(1-2):65-8. PubMed ID: 8395669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
    Diop L; Rivière PJ; Pascaud X; Junien JL
    Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.
    Diop L; Rivière PJ; Pascaud X; Dassaud M; Junien JL
    Eur J Pharmacol; 1994 May; 257(1-2):181-7. PubMed ID: 8082700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
    Dosaka-Akita K; Tortella FC; Holaday JW; Long JB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):631-7. PubMed ID: 8382278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naloxone, morphine and kappa-opioid receptor agonists on hypoxia/hypoglycemia-induced reduction of 2-deoxyglucose uptake in hippocampal slices from U-50,488H-tolerant rats.
    Shibata S; Tominaga K; Watanabe S
    Neurosci Lett; 1994 Dec; 182(2):155-8. PubMed ID: 7715801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
    Herrero JF; Headley PM
    Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of mu-mediated antitussive activity in rats by a delta agonist.
    Kamei J; Tanihara H; Kasuya Y
    Eur J Pharmacol; 1991 Oct; 203(1):153-6. PubMed ID: 1665789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
    Ho BY; Takemori AE
    J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL; Nayanar V; Walker JS
    Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors.
    Morrone LA; Romanelli L; Amico MC; Valeri P
    Br J Pharmacol; 1993 May; 109(1):48-52. PubMed ID: 8388301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stimulation of central kappa opioid receptors decreases male sexual behavior and locomotor activity.
    Leyton M; Stewart J
    Brain Res; 1992 Oct; 594(1):56-74. PubMed ID: 1334765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level.
    Alcaraz C; Milanés MV; Vargas ML
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1385-9. PubMed ID: 8396634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T; Ohno M; Ueki S
    Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.